On September 7, 2012, Health Canada notified the manager of the pharmacy where the MDMA will be stored for our planned Canadian study of MDMA-assisted psychotherapy for PTSD that the security upgrades planned for the pharmacy could meet legal requirements. The creation of additional security regulations following the initial inspection has delayed study initiation by more than 14 months, and Health Canada’s letter indicates that this will be the last round of changes required. Once the upgrades are complete, Health Canada will schedule their fourth inspection and hopefully grant the Controlled Substances License.
